1. Home
  2. MRVI vs ACCO Comparison

MRVI vs ACCO Comparison

Compare MRVI & ACCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • ACCO
  • Stock Information
  • Founded
  • MRVI 2014
  • ACCO 1893
  • Country
  • MRVI United States
  • ACCO United States
  • Employees
  • MRVI N/A
  • ACCO N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • ACCO Publishing
  • Sector
  • MRVI Health Care
  • ACCO Consumer Discretionary
  • Exchange
  • MRVI Nasdaq
  • ACCO Nasdaq
  • Market Cap
  • MRVI 371.8M
  • ACCO 353.3M
  • IPO Year
  • MRVI 2020
  • ACCO N/A
  • Fundamental
  • Price
  • MRVI $2.42
  • ACCO $4.00
  • Analyst Decision
  • MRVI Hold
  • ACCO Buy
  • Analyst Count
  • MRVI 10
  • ACCO 1
  • Target Price
  • MRVI $5.84
  • ACCO $6.00
  • AVG Volume (30 Days)
  • MRVI 1.4M
  • ACCO 523.2K
  • Earning Date
  • MRVI 08-11-2025
  • ACCO 07-31-2025
  • Dividend Yield
  • MRVI N/A
  • ACCO 7.48%
  • EPS Growth
  • MRVI N/A
  • ACCO N/A
  • EPS
  • MRVI N/A
  • ACCO 0.49
  • Revenue
  • MRVI $219,830,000.00
  • ACCO $1,581,200,000.00
  • Revenue This Year
  • MRVI N/A
  • ACCO N/A
  • Revenue Next Year
  • MRVI $7.23
  • ACCO $2.11
  • P/E Ratio
  • MRVI N/A
  • ACCO $8.19
  • Revenue Growth
  • MRVI N/A
  • ACCO N/A
  • 52 Week Low
  • MRVI $1.67
  • ACCO $3.32
  • 52 Week High
  • MRVI $9.60
  • ACCO $6.44
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.60
  • ACCO 59.22
  • Support Level
  • MRVI $2.28
  • ACCO $3.90
  • Resistance Level
  • MRVI $2.47
  • ACCO $4.01
  • Average True Range (ATR)
  • MRVI 0.14
  • ACCO 0.10
  • MACD
  • MRVI -0.01
  • ACCO 0.01
  • Stochastic Oscillator
  • MRVI 27.45
  • ACCO 79.91

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.

Share on Social Networks: